Last reviewed · How we verify

NCT06867276

Low Level Laser Versus Polarized Light in the Treatment of Acne Vulgaris

Completed NA Last updated 10 March 2025
What this trial tests

NA trial testing Excimer laser in Low Level Laser Therapy in 50 participants. Completed in 22 December 2024.

Timeline
15 January 2024
Primary endpoint
22 November 2024
22 December 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date15 January 2024
Primary completion22 November 2024
Estimated completion22 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 25, any sex, with Low Level Laser Therapy or Acne Vulgaris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is designed to compare clinically the therapeutic applications between low level laser therapy (excimer laser) and non-laser polarized light (Bioptron prol) in the treatment of Acne vulgaris.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Excimer laser

Trials testing the same drug.

Other recruiting trials for Low Level Laser Therapy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06867276.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing